Finance

Beta
Lists
002907:SHE
Chongqing Pharscin Pharmaceutical Co Ltd
CN¥14.18
-1.25%
(-0.18) 1D
Jul 10, 3:04:48 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002907...
Open
CN¥14.58
High
CN¥14.80
Low
CN¥14.00
Mkt. cap
6.00B
Avg. vol.
5.85M
Volume
19.18M
Dividend
0.53%
Quarterly dividend
CN¥0.02
Ex-dividend date
Jun 4, 2026
P/E ratio
102.95
52-wk high
CN¥21.52
52-wk low
CN¥11.42
EPS
CN¥0.14
Shares outstanding
417.60M
No. of employees
1K
Open
CN¥14.58
High
CN¥14.80
Low
CN¥14.00
Mkt. cap
6.00B
Avg. vol.
5.85M
Volume
19.18M
Dividend
0.53%
Quarterly dividend
CN¥0.02
Ex-dividend date
Jun 4, 2026
P/E ratio
102.95
52-wk high
CN¥21.52
52-wk low
CN¥11.42
EPS
CN¥0.14
Shares outstanding
417.60M
No. of employees
1K
News stories
From sources across the web
About Chongqing Pharscin Pharmaceutical Co Ltd
CEO-
Employees1.44K
FoundedNov 4, 1996
Headquarters-
SectorPharmaceutical industry
Websitepharscin.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
202.97M
184.00M
201.23M
211.85M
Cost of goods sold
85.12M
78.94M
92.46M
84.88M
Cost of revenue
85.12M
78.94M
92.46M
84.88M
Research and development expenses
24.74M
22.20M
30.52M
19.49M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
83.41M
69.57M
82.65M
73.76M
Operating expense
111.98M
92.39M
117.57M
96.54M
Total operating expenses
197.10M
171.34M
210.02M
181.41M
Operating income
5.87M
12.66M
-8.79M
30.43M
Other non operating income
-85.51K
-15.95M
15.80M
674.52K
EBT including unusual items
12.82M
27.42M
-12.09M
37.60M
EBT excluding unusual items
22.25M
-1.67M
-1.01M
34.28M
Income tax expense
890.22K
11.79M
618.10K
8.69M
Effective tax rate
6.94%
43.00%
-5.11%
23.12%
Other operating expenses
4.43M
906.92K
5.32M
1.93M
Net income
13.60M
18.51M
-7.37M
32.79M
Net profit margin
6.70%
10.06%
-3.66%
15.48%
Earnings per share
-
-
-
-
Interest and investment income
16.52M
1.85M
150.51K
3.24M
Interest expense
-49.90K
-238.82K
-8.19M
-70.53K
Net interest expenses
16.47M
1.61M
-8.03M
3.17M
Depreciation and amortization charges
-
-
-
-
EBITDA
27.18M
33.92M
12.63M
51.86M
Gain or loss from assets sale
-
-
-10.25M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer